Increased number of Campylobacter bacteraemia cases in Sweden, 2014
| Autor: | Heli Harvala, Mia Brytting, K. Tegmark Wisell, E. Ydring, Barbro Mäkitalo, Anders Wallensten, Cecilia Jernberg, T. Söderblom |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Adult
Male 0301 basic medicine Microbiology (medical) Pediatrics medicine.medical_specialty Adolescent 030106 microbiology Population Bacteremia medicine.disease_cause Young Adult 03 medical and health sciences 0302 clinical medicine Campylobacter Gastroenteritis Campylobacter Infections medicine Humans Clinical significance 030212 general & internal medicine Young adult Child education Aged Aged 80 and over Sweden Bacteriological Techniques education.field_of_study business.industry Incidence Public health Incidence (epidemiology) Campylobacter Infant Newborn Infant General Medicine Middle Aged medicine.disease Infectious Diseases Child Preschool Female business |
| Zdroj: | Clinical Microbiology and Infection. 22:391-393 |
| ISSN: | 1198-743X |
| DOI: | 10.1016/j.cmi.2015.11.013 |
| Popis: | Here were report the increased numbers of Campylobacter detections in blood samples, first noted in July 2014, in Sweden. We investigated whether this increase was a result of a general increase in incidence of Campylobacter infections in Sweden or if the observed increase resulted from increased testing or from a change in laboratory methods. Campylobacter is the most common bacterial cause of gastroenteritis in Europe, with over 200 000 laboratoryconfirmed cases occurring yearly. Although the outcome of Campylobacter gastroenteritis is typically good, infections have been occasionally linked to systemic invasive disease and postinfectious complications. On the basis of previous studies, the incidence of campylobacteraemia varies between 0.1% and 0.4% of the total incidence of Campylobacter infections [1–3]. However, clinical significance of campylobacteraemia is poorly understood, and it has been suspected to have been an underestimated event [1,4]. To investigate whether the incidence of Campylobacter infections had generally increased in Sweden, we reviewed data on all notified Campylobacter cases (including cases of bacteraemia) between 2010 and 2014. Because of nationwide mandatory reporting, both treating physicians and clinical microbiology laboratories in Sweden (population of 9.64 million people) report all Campylobacter infections to the database maintained at the Public Health Institute of Sweden, from which a total of 39 832 cases of Campylobacter infections were identified (Fig. 1a). From those, 133 were cases of |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|